Power Law company profile

Mesoblast

Biotech & Life Sciences · Melbourne, Australia · Founded 2004 · IPO 2004 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.78B

Market cap · Apr/2026

Revenue

$17M

Latest reported FY

Investors

1 investor on Mesoblast's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

NDRC

Global footprint

Where Mesoblast has talent and traffic

Web traffic by country

12K monthly visits
across markets

🇦🇺 Australia47.5%

🇺🇸 United States38.3%

🇮🇳 India9.2%

🏳️ New Zealand6.7%

🇵🇭 Philippines0.8%

Top 5 markets shown

Patent intelligence

$242M patent portfolio · 86 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$242M

13.6% of market cap · 8.4× smaller than top peer Ablynx ($2B)

86 active patent families

Where Mesoblast innovates Molecular biologyBiochemistryBiophysicsMesenchymal stem cellStem cell

Above peer median on Market

Quality vs same-sector peers

Mesoblast on the five Patsnap quality dimensions

Mesoblast in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Mesoblast concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Mesoblast and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Mesoblast on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo